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Summary: Interactions between cancer cells and laminin play an important role in the metastatic cascade. The aim
of this retrospective study was to evaluate the presence and the prognostic significance of autoantibodies to laminin
in sera of patients with breast cancer. Our study population consisted of 71 high-risk primary breast cancer patients
(median follow-up, 6 years). IgG, IgA and IgM were analysed at the time of surgery and before any treatment was
given. Concentrations were measüred by enzyme immunoassay with a highly purified antigen. IgG, IgA and IgM
anti-laminin median values were, respectively 117%, 130% and 97% of normal absorbance. Higher concentrations
of IgM to laminin were found in pre-menopausal patients äs compared with post-menopausal patients (p < 0.001).
Patients with high concentrations of IgG to laminin had lower disease-free (p = 0.003) and overall survival rates
(p = 0.003). In breast cancer, assay of IgG to laminin could thus provide a cheap and easy prognostic index
available for all patients.
Introduction ies to laminin in sera of 71 high-risk primary breast
. ., ,. - . - . . . , , ., cer patients. The association of IgG, IgA and IgM anti-Autoantibodies of vaiious specificities have been ident- . f . .. . . . . c ^ ,. r.- , . - o · « . " ' · " " ^ , - j- laminin with classical prognostic factors, disease-freemed m the sera of patients süffenng from neoplasic dis- - .. . , *.j- j * j * · -„ « T , M i · and overall survival was studied to determme their poss-eases (l—5). In breast cancer, untü now, only anti-nu- ~ " . . , Ä .. , . , ' ., ' . : ible chmcal usefulness.clear and anti-smooth muscle autoantibodies have been
correlated with the clinical cpurse of the disease (6).
Cancer invasiveness is deterrnined by basement mem- Materials and Methods
brane fragmentation. Interactions betweep cancer cells patients
and laminin, the main glycoprotein of basement mem-
u^ i · - «A * i · *i. * * 4 j A Our study population consisted of 71 high-risk primary breast can-branes, play an important role m the metastatic cascade cer -.** ̂  age = 5] years; ̂  = ̂ 3^6/years) who
(7). In addition, laminin-derived peptides stimulate were treated by the same clinical team between 1984 and 1988
angiogenesis and tumour growth f(8). (tab- 0· T*16 median follow-up was 6 years (maximum follow-up, 8
years). All patients had undergone partial mastectomy with axillary
The aim of this retrospective study was to evaluate the lymph node clearance and post-operative Irradiation äs part of the
prcs.nceandftep^os.iosigmfloanceofau^bod- ^ ^-^
patients had distant metastases and 20 had died of cancer.
~~ Macroscopic tumour size was defined äs the largest tumour dia-
1 This work was suppoted by grant No. 6257 from Association meter measüred by the patholögist. Axillary node involvement was
pour la Recherche sur le Cancer. determined by pathological examination of at least 10 nodcs per
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Tab. l Characteristics of patients
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SBR: Scarff, Bloom, Richardson classification (9)
Statistics
Relationships between autoantibody concentrations were analysed
using the Spearman rank test; differences in the distribution among
patients subgroups were studied using the Μαηη-Whitiiey U test.
Survival rates, ealculated according to the Kaplan-Meier method
were compared using the log rank test. The cut-off value for auto-
antibodies to laminin was establishedr in order to achieve the high-
est chi-square value (χ?) resulting from log rank tests.
Results
Distribution of autoantibodies to laminin
IgG, IgA and IgM anti-laminin concentrations (relative
absorbance values) were* respectively: means ± SD:
133 ± 79%, 159 ± 93% and 124 ± 90%; medians:
117%, 130% and 97% (flg. 1). The concentrations of
IgG and IgA autoantibodies to laminin were highly cor-
related (p < 0.001). IgM concentrations were more
weakly correlated to IgG (p = 0.002) and to IgA con-
centrations (p = 0.02).
Association between autoantibodies to
laminin and tumour characteristics
Higher concentrations of IgM to laminin were fpund in
pre-menopausal patients, compared with posUmeno^
pausal patients (median 138 vs 85% relative absorbance)
(p < 0.001). No other significant correlation was found
between autoantibodies to laminin and tumour size, axil-
lary node involvement, histological grade or steroid re-
ceptors.
patient. The histological grade was determined using the method
of Scarff, Bloom and Richardson s decribed in 1. c. (9).
Assay of steroid receptors
Oestrogen and progesterone receptors were assayed using the dex-
tran-coated charcoal method (cut-off, 10 nmol/kg protein). Quality
control was assured by frequent testing with both internal controls
and European Organization for Research and Treatment of Cancer
(EORTC) Standards (10).
Assay of autoantibodies to laminin
The sera were collected at the time of surgery and prior to therapy
and stored at -20 °C. Concentrations of autoantibodies to laminin
were measured by enzyme immunoassay s previously described
(11). Laminin antigen was highly purified from mouse Engelbreth-
Holm-Swarm sarcoma extracts by anion exchange chromatography
and gel filtration s previously described (12).
Calculation
Results of autoantibody assay are expressed s relative absorbarice:
absorbance of tested serum
Associations between autoantibodies to
laminin and other factors with (disease-free)
survival
Menopausal Status, tumour grade, oestrogen receptof












IgG to Jaminin IgA to laminin IgM to laminin
Fig. l Distribution of antibodies to laminin in the sera of 71
breast cancer patients. Concentrations are expressed s relative ab-
sorbance (comparison with a pool of 80 normal sera), see sectiori
"Calculation", - »v
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association with disease-free and overall survival.
Larger tumour size was associated with reduced disease-
free (p = 0.0003) and overall survival (p = 0.0002). The
number of axillary lymph nodes involved was positively
associated with both a shorter disease-free (p = 0.02)
and overall survival (p = 0.01).
Analysis of a possible correlation between autoantibod-
ies and outcome showed that patients with high concen-
trations of IgG to laminin had lower survival rates. The
cut-offvalue was established to achieve the best clinical
correlation. The highest 2 was observed at a cut-off of
210% relative absorbance (disease-free survival,
2 = 8.96, p = 0.003; overall survival, 2 = 8.57,
p = 0.003) (fig. 2). No significant association could be
found between prognosis and the concentrations of IgA
or IgM to laminin.
Discussion
We demonstrate here a high incidence of antibodies to
laminin to the sera of breast cancer patients at the time
of diagnosis and before any therapeutic Intervention.
Dysregulation of the immune System and accelerated ly-
sis of neoplastic tissues have been proposed äs Stimuli
for autoantibody production in patients with maiignanc-
ies (13).
Laminin has been implicated in cell adhesion and mi-
gration. In previous studies, it was suggested that intra-
tumoural laminin distribution (14), laminin receptors
(15), serum (16) and urinary (17) laminin fragments may
have a prognostic value in breast cancer. We found a
statistically significant association between IgG anti-
bodies to laminin and pöor prognosis. Although this as-
sociation needs to be confirmed in prospective clinical
trials including more patients, assay of IgG to laminin
would provide a cheap and easy test ävailable for all
patients.
Several piroteases, including principally the cathepsin D
(18) and the urokinase plasminogen activator (19), have
been associated with an increäsed risk of developing
metastasis in breast cancer. Intratumouräl proteases only
reflect tumour aggressiveness at the time of sufgery,
IgG low
IgG high






Fig. 2 Disease-free and overall survival of 71 breast cancer pa-
tients according to serum concentrations of IgG antibody to lami-
nin. Concentrations are expressed äs absorption (comparison with
a pool of 80 normal sera), see section "Calculation"; low: < 210%
(n = 60); high: > 210% (n = 11).
whereas autoantibodies to laminin can be interpreted äs
the cumulative result of both tumour aggressiveness and
the time course of the disease.
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